Artemis Medicare Services Limited has announced the following key details regarding its dividend for FY25 and related tax deductions:

• The Board of Directors, in its meeting held on May 12, 2025, recommended a Final Dividend of Re. 0.45 per Equity Share of face value of Re. 1/- each for the financial year 2024-25 (FY25).
• The record date for dividend entitlement is Friday, July 11, 2025.
• The dividend will be paid after approval by shareholders at the Company's 21st Annual General Meeting (AGM).
• As per the Income-tax Act, 1961, as amended by the Finance Act, 2020, the Company will withhold taxes at prescribed rates on the dividend paid to shareholders. The tax deduction rate will vary based on the shareholder's residential status, category, and submitted documents.
• For Resident Shareholders, the tax deduction rate is generally 10% (with valid PAN) or 20% (without/invalid PAN). No tax will be deducted for resident individuals if the total dividend from the Company during FY26 does not exceed ₹10,000. Exemptions or lower rates apply for those submitting Form 15G/15H or a lower/nil tax deduction certificate under Section 197.
• For Non-Resident Shareholders, the tax deduction rate is 20% (plus surcharge and education cess, as applicable) or the Double Taxation Avoidance Agreement (DTAA) rate, whichever is lower, subject to submission of required documents like Tax Residency Certificate (TRC) and Form 10F.
• Shareholders must ensure their bank account details are updated. For shares held in physical mode, dividend payments will only be made electronically after furnishing PAN, contact details, bank details, and specimen signature to the Registrar and Transfer Agent (RTA).
• All applicable documents for tax exemption or lower deduction must be submitted to Alankit Assignments Limited (RTA) by email at rta@alankit.com by Wednesday, July 16, 2025. No communication or documentation on tax determination/deduction will be entertained after this date.